Press Releases

Press Releases

Summary Toggle PDL BioPharma Enters into $51.4 Million Capital Provision Agreement with Epps Investments LLC Regarding PDL's Previously Announced Settlement Agreement with Wellstat

RENO, Nev. , Dec. 14, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces it has entered into a Capital Provision Agreement (the "Agreement") with Epps Investments LLC ("Epps"). Under the terms of the Agreement, Epps will pay PDL $51,391,184 no later than

Dec 14, 2020
Summary Toggle PDL Announces Timeline for Voluntarily Delisting from Nasdaq

Expects to File a Certificate of Dissolution on January 4, 2021 Trading in PDL's Common Stock on Nasdaq to be Suspended Prior to Market Opening on December 31, 2020 INCLINE VILLAGE, Nev. , Dec. 8, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that

Dec 8, 2020
Summary Toggle PDL BioPharma Reports 2020 Third Quarter Financial Results and Sets Date To File a Certificate of Dissolution

- Consummated critical monetization transactions during third quarter, including the sale of its Noden pharmaceutical business and of a basket of royalties to SWK Holdings. Also entered into a settlement agreement with Wellstat. Subsequently completed the spin-off of its medical device company,

Nov 11, 2020
Summary Toggle PDL BioPharma Reschedules Third Quarter 2020 Financial Results and Business Update

Conference Call to Wednesday, November 11 at 4:30 p.m. Eastern Time INCLINE VILLAGE, Nev. , Nov. 6, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces it has rescheduled the date for announcing third quarter 2020 financial results and holding a conference

Nov 6, 2020
Summary Toggle PDL BioPharma to Announce Third Quarter 2020 Financial Results and Provide a Business Update on November 9, 2020

INCLINE VILLAGE, Nev. , Oct. 29, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its third quarter 2020 financial results for the period ended September 30, 2020 , on Monday, November 9, 2020 after market close.

Oct 29, 2020
Summary Toggle PDL BioPharma Completes Spin-Off of LENSAR

INCLINE VILLAGE, Nev. , Oct. 2, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that it has completed the previously announced spin-off of its femtosecond laser system business, LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR").

Oct 2, 2020
Summary Toggle PDL BioPharma to Complete Spin-Off of LENSAR, Inc. on October 1, 2020

Declares Record Date of September 22, 2020 and Expected Share Distribution Date of October 1, 2020 Conference call with slide presentation today beginning at 4:30 p.m. Eastern time INCLINE VILLAGE, Nev. , Sept. 10, 2020 /PRNewswire/ -- PDL BioPharma, Inc.

Sep 10, 2020
Summary Toggle PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital

INCLINE VILLAGE, Nev. , Sept. 9, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the closing of the sale of its wholly owned subsidiaries Noden Pharma DAC and Noden Pharma USA (collectively " Noden ") to Stanley Capital .

Sep 9, 2020
Summary Toggle PDL BioPharma Announces Sale of Kybella®, Zalviso® and Coflex® Royalties to SWK Holdings Corporation

INCLINE VILLAGE, Nev. , Aug. 31, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a definitive agreement for the sale of three royalty interests for Kybella ® , Zalviso ® , and Coflex ® (collectively the "Royalties") to SWK

Aug 31, 2020
Summary Toggle PDL BioPharma Announces Offer to Purchase Convertible Notes Due 2021 and 2024

INCLINE VILLAGE, Nev. , Aug. 28, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that holders of its 2.75% Convertible Senior Notes due in December 2021 (the "2021 Notes") and in December 2024 (the "2024 Notes" and together with the 2021 Notes, the

Aug 28, 2020
Summary Toggle PDL BioPharma Announces Filing of a Form 10 Registration Statement with the Securities and Exchange Commission for a Potential Spin-off of LENSAR to PDL's Stockholders

INCLINE VILLAGE, Nev. , Aug. 26, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that its majority owned medical device subsidiary, LENSAR, Inc. (" LENSAR "), has filed a registration statement on Form 10 with the Securities and Exchange Commission

Aug 26, 2020
Summary Toggle PDL BioPharma Enters Into Settlement Agreement with Wellstat

INCLINE VILLAGE, Nev. , Aug. 12, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces it has entered into a settlement agreement (the "Settlement Agreement") with related entities of Defined Diagnostics, LLC (f/k/a Wellstat Diagnostics, LLC ) (" Wellstat

Aug 12, 2020
Summary Toggle PDL BioPharma Reports 2020 Second Quarter Financial Results

- Accomplished Important Asset Monetization Milestones with the Distribution of Evofem Biosciences Shares to PDL Stockholders and the Anticipated Sale of Noden to Stanley Capital - Announced the Filing of a Form 10 with SEC for Potential Spin-off of LENSAR - Continues to Seek Potential

Aug 6, 2020
Summary Toggle PDL BioPharma to Announce Second Quarter 2020 Financial Results on August 6, 2020

INCLINE VILLAGE, Nev. , July 30, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or "the Company") (Nasdaq: PDLI) announces that it will release its second quarter 2020 financial results for the period ended June 30, 2020 , on Thursday, August 6, 2020 , after market close.

Jul 30, 2020
Summary Toggle PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital

INCLINE VILLAGE, Nev. , July 30, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing of a definitive agreement for the sale of 100% of the outstanding stock in its wholly owned subsidiaries Noden Pharma DAC and Noden USA (collectively " Noden ")

Jul 30, 2020